Stefano Indraccolo

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 386 citations

Medicine, Oncology, Pharmacology +13

Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis

Michele De Palma, Roberta Mazzieri, Letterio S. Politi et al. · Cancer Cell · 2008 · 303 citations · Full text

Medicine, Immunology, Oncology +14

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation

Anna Pastò, Chiara Bellio, Giorgia Pilotto et al. · Oncotarget · 2014 · 292 citations · Full text

Medicine, Cell Biology, Oncology +17

Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia

Erich Piovan, Jiyang Yu, Valeria Tosello et al. · Cancer Cell · 2013 · 266 citations · Full text

Medicine, Oncology, Pharmacology +15

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150

Margherita Ghisi, Alberto Corradin, Katia Basso et al. · Blood · 2011 · 227 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +14